The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Surfi- in our Agm it was stated that potential partners/buyers have said “show us your data” well this is coming imminently. Let’s see if the bod can attract a good deal - and I know the board have been drumming that drum for many years but now it’s time to deliver. Not a fan of SP by the way. Another thing for people to consider will be the imminent funding raise for phase 2 - this will hold us back a little.
Exactly, I was buying these at 0.4p via the Primary Bid offer in June 2019 and had been snapping them up for below .3p in 2015. It's interesting to note that the share price then was pretty comparable to where it is today, since the 50-1 consolidation of shares. If we get good news on the P1a trial this will soar back up again as it has done in the past. Maybe not by your 4,600% example but if we do get a significant licencing deal from a major player then 200p to 300p is not un-reasonable....
Good luck, Brighty
All good here Silver yes will be good to see you too along with the others from last year and see what they have made of what’s happened, like you said hopefully in a better position than we are now .Still hoping 1802 goes into tox studies this year and at least by the AGM we should know who the mystery pharma is who took on 737
GLA
We're down more than MATD is right now...and the yak has had a bad Rns this morning 🧐
Hi Gunner yes look forward to seeing you in December hopefully SAR will be in a different phase by then and things will be looking up. I wanted to ask about PH at the last AGM but as you rightly observe there was barely any time allowed! Maybe we go armed with chains and padlocks!!😵💫😵💫 Hope all is good with you .
Hi Silver hope all is well I think we know TM was happy with PH last time he spoke on the IM and would be nice to ask him that question and why he was ,also would be respectful of the BOD at the next AGM to not have a time bound meeting and should be pencilled in for all the morning or afternoon and hopefully they can answer the questions there and then from shareholders on the floor and questions submitted beforehand I think it it the least they can do especially as it’s been the shareholders that have saved this company I would also put it out there for more shareholders to try and attend the AGM as it is in their interest and is good to meet like minded people within SAR
Let’s hope 1801 data data data results is as good as we expect and we can build from there going forward
GLA
1. Those that understand this share will know that we gained x46 approx from .2p to 9p+ in pre consolidation money (or from 10p to 450p+ in post consolidation money). i.e. A 4,600% gain.
2. We had regular dilutions along the way but for those that invested, in particular, between 2018 and 2021 and who bought at the bottom at .2p and sold at 8 or 9p understood the bigger picture rather than a few 10 % here or a few 20% gains there. i.e. Big money was made on the x 4,600% rise and surprise surprise the current share price is back where it was pre-the mega rise. Just in time for data to be released.
3. Sareum is a company that has its global patent ducks in a row.
4. Sareum has already produced data showing that its lead candidate SDC-1801 is superior to Dexamethasone in a trial.
5. Sareum has shown that its science in combo with Astra Zeneca's WEE1, Merck’s Keytruda, Eli Lilly's Gemcitabine works.
6. We've not had any significant "fails" in 20 years.
7. The Phase 1a trial includes a single ascending dose study, a multiple ascending dose study and a food effects study. If the results are as good as we expect - and all the news has been encouraging to date - a big pharma is likely to swoop in with a licencing deal.
8. We already know that the safety and pharmacokinetics data from the initial cohorts in Part 1 of the SDC-1801 trial indicate a favourable profile and fully support oral dosing of patients once daily.
9. We have been briefed that the full safety data from the Phase 1a trial is expected to be available during Q2. We are in this period, so news could come at any time.
Therefore, those with a vision and a medium term strategy to "Mega Multi-Bag will not be that worried about the daily share price shenanigans and fluctuations. We've seen it all before.
I have written to Lauren Williams and Dr Parker (registered letter) to ask the current situation with RF in terms of outstanding liabilities. Also took the opportunity to ask how much PH had cost us since October 2021 and could they advise what they believe the benefits to SAR have been from the association with PH.
Colbalt there remains way to many unknowns and variables, will we get a Mad finish RNS or are we to wait until the end of June for full data, no guarantees that will be positive enough to move forwards, market has no idea if we can fund a P2a, market has no idea what’s happening with SRA737…..
@Nicely....As I used to say to my ex wife ....'One swallow doesn't make my summer', it was normally said when it was my birthday.
gla x
Yeah loads of buys going through
What concerns me is the low base we seem to be getting. If we get fantastic news, even a high percentage increase will not get us to a decent level. Then, what about the inevitable profit taking after the news? Feeling a bit dissatisfied with the SP atm.
GLA
Abe, no… not a ramper or a de-ramper, just an investor with a view. Dropped in and out of this board for many years, but never bothered posting. The end game is in sight now so let’s see where we end up. Here’s to maximising our returns .
I kind of agree, perhaps not exactly 20p but the early 20ps. The RF finance is still in play, some selling to come and news needed. The bull run is still potentially around the corner, I'm thinking there's a possibility of a 5x here on news
Got alot of stick from blinded bulls at 32/33p when i said its likely to cool off back to 25p
And here we are...
Maybe a bounce to a lower high into end of week
Ultimately i see it back at 20p
I still think there is an overhang. There wasn't enough time to offload the full 3 million shares issued before the final tranche were Issued. I think the big sales we saw were RF trying or maybe required to keep under 3%. Like I said all we really know is they have less than 3%.
In my opinion they are gone - except for the warrants which will be forward sold at a time of their choosing and we will hear via RNS after it is done.
Mathsprof has done a good job of keeping an eye on the numbers (as much as anyone can).
The current fluctuations in price are the Share finding it's level.
IMHO.
I think they will be out by the end of next week. I also predict that today's sells will be reported @26/7p when it lands tomorrow.
Fair point, Potnak.
Aber - I'm always a bit wary of posters using the company name in their moniker.
Exactly Laesar... oh its going down cos Roverfort are selling or alternatively its going up cos there's news soon. In reality nobody had a bloody clue. If this gets back to anywhere near where it was a year agoI will eat my hat.
From Yesterday 10 minutes before the close @31.325p.
Could be RFort getting rid of their last subs.
KR
ZA
HBD .. Careful with LSESAR .. only a couple of posts .. account set up only for one reason ... IMHO it will be a further alias account of our lovely deramping crew ... All Just IMHO - I could be wrong but no. of posts says a lot really
I don't think that is tight HBD. The balance of the RF facility isn't paid back via the sell price they get. It was paid back at the placing price minus a discount. That how sareum knew how many shares to issue to settle. They couldn't do more than 3 million as that would risk a TR1 and maybe there was a clause in the contract to protect sareum in that respect. They are nearly out and have made a nice profit to boot. Still have warrants too. As do other investors. The dillution isn't done yet but hopefully, we won't care as the warrants will be excised on some stocking news.
Lsesar - thanks for your posts. In my opinion, there has been sack loads of evidence of market manipulation with this share. Unfortunately legislative scrutiny has been weakened across the range of public bodies in UK. So a request to the Financial Ombudsman to take a look would seem unlikely to get very far.